E. Ohman J:Or Asset Management Ab Catalent, Inc. Transaction History

E. Ohman J:Or Asset Management Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Apr 05, 2024	SELL	$72.36 - $113.1 $492,048 - $769,080	-6,800 Closed	0 $0
Q2 2022 Apr 05, 2024	SELL	$87.2 - $114.05 $122,080 - $159,670	-1,400 Reduced 17.07%	6,800 $730 Million
Q3 2021 Apr 05, 2024	BUY	$109.17 - $142.35 $152,838 - $199,290	1,400 Added 20.59%	8,200 $1.09 Billion
Q2 2021 Apr 05, 2024	BUY	$100.34 - $115.69 $341,156 - $393,346	3,400 Added 100.0%	6,800 $735 Million
Q3 2020 Apr 05, 2024	BUY	$72.74 - $92.5 $247,315 - $314,500	3,400 New	3,400 $291 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.